The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers

BACKGROUND: Roux-en-Y gastric bypass (RYGB) surgery is currently the most effective treatment of obesity, although limited by availability and operative risk. The gut hormones Glucagon-like peptide-1 (GLP-1), Peptide YY (PYY), and Oxyntomodulin (OXM) are elevated postprandially after RYGB, which has...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Tricia, Behary, Preeshila, Tharakan, George, Minnion, James, Al-Najim, Werd, Albrechtsen, Nicolai J. Wewer, Holst, Jens J., Bloom, Stephen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2017
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505203/
https://www.ncbi.nlm.nih.gov/pubmed/28379519
http://dx.doi.org/10.1210/jc.2017-00469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505203/
https://www.ncbi.nlm.nih.gov/pubmed/28379519
http://dx.doi.org/10.1210/jc.2017-00469

Ejemplares similares